Vol. 275, Issue 1, F164-F172, July 1998
Direct visualization of renal vascular morphogenesis in
Flk1 heterozygous mutant
mice
Barry
Robert,
Patricia L.
St. John, and
Dale R.
Abrahamson
Departments of Comparative Medicine and Cell Biology, University
of Alabama at Birmingham, Birmingham, Alabama 35294-0019
 |
ABSTRACT |
Flk1, a receptor tyrosine
kinase for vascular endothelial growth factor (VEGF), is the earliest
known marker for endothelial precursors (angioblasts). We examined
heterozygous mice in which the Flk1
gene was partially replaced by a promoter-less
LacZ insert and used
-galactosidase
histochemistry to view cells transcribing Flk1. In day
10 (E10) embryos, a
Flk1-positive network surrounded the metanephric blastema, and, at
E11, a vessel entered the metanephros from its ventral aspect alongside the ingrowing ureteric bud. However,
aortic branches did not engage embryonic kidneys at these time points.
In newborns,
-galactosidase was localized exclusively and intensely
to endothelial cells of all vessels and glomeruli. In contrast, when
E12 kidneys grown in organ culture for
6 days were examined, only scattered Flk1-positive cells were seen,
glomeruli were unlabeled, and vessels were absent. When organ-cultured
kidneys were then grafted into wild-type anterior eye chambers,
numerous Flk1-positive endothelial cells in vessels and glomeruli were found, all stemming from the graft. Image analysis showed that grafts
with the most abundant glomerulo- and tubulogenesis were also those
with the richest expression of Flk1. We conclude that 1) kidney microvessels precede renal
artery development, 2) angioblast differentiation is arrested in organ culture but released on grafting when vasculogenesis resumes, and 3)
nephrogenesis and microvessel assembly are tightly coupled in vivo.
angiogenesis; nephrogenesis; vasculogenesis
 |
INTRODUCTION |
THE EARLIEST VASCULATURE of the mammalian embryo forms
by vasculogenesis, which involves the in situ differentiation of
mesodermally derived endothelial precursors called angioblasts that
then coalesce into vessels (20). Blood vessels also form in the embryo
by angiogenesis, which represents the sprouting of new vessels from those already present. Both vasculogenesis and angiogenesis occur throughout embryogenesis, whereas blood vessel growth in adults apparently occurs only by angiogenesis (19).
A number of growth factors that initiate and control embryonic vascular
morphogenesis have recently been identified (6, 8, 21). Targeted
mutations of vascular endothelial cell growth factor (VEGF) and two of
its receptor tyrosine kinases, Flk1 (VEGFR2) and Flt1 (VEGFR1), have
shown that these three proteins are especially crucial for embryonic
blood vessel development in mice (2, 5, 7, 27).
Flk1 and
Flt1 homozygous null mutants both die
at approximately embryonic day 8.5 (E8.5) (7, 27). In Flk1 mutants, there is complete
failure of development of endothelial and hematopoietic cells from
mesodermal precursors (27). By contrast, angioblasts are present in
Flt1 null mutants, but these cells
form abnormal, disorganized blood vessels (7). Flk1 expression therefore appears to be important for initial differentiation of
endothelial cells, whereas Flt1 mediates somewhat later stages of blood
vessel assembly. Both VEGF homozygous
and heterozygous mutants die in utero by
E12 because of vascular
insufficiencies, indicating that expression of both
VEGF alleles are required for normal
blood vessel development (2, 5). Another endothelial-specific receptor
tyrosine kinase, Tie1, is also expressed in endothelial precursors, but
the ligand for this receptor has not yet been identified. The exact
role Tie1 plays in early endothelial differentiation processes is also
unclear, and homozygous null mutants have been reported to die as early
as E13 (18) and with extensive
hemorrhages around the time of birth (25).
Targeted mutations of VEGF and genes
encoding its two high-affinity receptors,
Flk1 and
Flt1, have been very informative, but
their embryonic lethality prior to the onset of metanephrogenesis has
limited their usefulness to investigate kidney blood vessel formation specifically. Nonetheless, these regulators of vascular development have been localized to the developing metanephros, and
expression of VEGF,
Flk1, and
Flt1 mRNAs and proteins has been
identified by in situ hybridization and immunocytochemistry, respectively (11, 17, 22, 28, 30). Because of the relatively low
resolution inherent with many in situ hybridization procedures and the
sensitivity of the Flk1 receptor to even modest fixation, these earlier
investigations have generally provided imprecise morphological
definitions. In the present study, we used heterozygous Flk1tm1Jrt
transgenic mice, in which the first coding exon of the
Flk1 gene has been replaced by a
promoter-less LacZ insert (27), which encodes the
-galactosidase enzyme. As mentioned earlier, homozygous Flk1 null mutants die at
~E8.5, but heterozygous mice develop normally. By processing tissues from heterozygotes histochemically for
-galactosidase activity, we directly and clearly visualized cells
expressing Flk1 before, during, and after metanephrogenesis. Our
results show that the first metanephric vascular connections are not
made with the aorta but instead with a peripheral vascular network that
forms around the blastema at E10. We
also provide further evidence that angioblasts are capable of
establishing the entire renal microvasculature in vivo by
vasculogenesis.
 |
MATERIALS AND METHODS |
Animals. All mice for these
experiments were taken from colonies of
Flk1tm1Jrt and
C57BL/6J mice that we founded in stocks obtained from the Jackson
Laboratory (Bar Harbor, ME). To identify animals carrying the
LacZ insert in the
Flk1 gene, offspring of
Flk1tm1Jrt mice
were genotyped at weaning by PCR using 3' CTTATGGGAGAGGTRGGGCTT and 5' AGGTGAGATGACAGGAGATC as primers, which amplified the
neomycin resistance gene insert. The colony was maintained as
heterozygotes (Flk1 +/
).
-Galactosidase
development procedures. Timed pregnant mice were
anesthetized and killed by cervical dislocation at the indicated gestational day (date of the vaginal plug, day
0). Whole embryos were collected and placed in 0.2%
paraformaldehyde in 0.1 M
piperazine-N,N'-bis(2-ethanesulfonic acid) (PIPES), pH 6.9, at 4°C overnight. To examine metanephric development in E10 and
E11 animals, the anterior halves were
discarded, and gastrointestinal tissues were removed from the posterior
body cavities. For E12 embryos,
isolated preparations consisting of paired mesonephroi and metanephroi
with attached aorta were dissected free of surrounding tissues.
Dissected embryos and tissues were rinsed three times in
phosphate-buffered saline (PBS) containing 2 mM
MgCl2 and incubated in detergent
rinse (0.1 M phosphate buffer, pH 7.3, 2 mM
MgCl2, 0.01% sodium deoxycholate,
and 0.02% Nonidet P-40) for 10 min on ice. Color development was
carried out overnight at 37°C in color development solution
[detergent rinse, 5 mM potassium ferricyanide, 5 mM potassium
ferrocyanide, 20 mM tris(hydroxymethyl)aminomethane, pH 7.3, and 1 mg/ml
5-bromo-4-chloro-3-indolyl-D-galactopyranoside (X-gal; Sigma Chemical, St. Louis, MO)] (9). Tissues were washed three times in PBS with 2 mM MgCl2
and refixed in Karnovsky's fixative (1.6% paraformaldehyde and 3%
glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4). Tissues were
washed, dehydrated through graded ethanol series, and embedded in
epoxy, using standard procedures. Serial sections, 2-3 µm thick,
were cut and examined by light microscopy using Nomarski optics.
Kidneys from newborn and adult Flk1
+/
mice were processed for microscopy as described below for
metanephric organ cultures and anterior chamber grafts.
Organ culture of metanephric kidneys.
Metanephric kidneys were aseptically microdissected from
E12 embryos, and pairs of metanephroi from individual embryos were placed in separate chambers of 12-well tissue culture dishes (Falcon, Oxnard, CA) containing sterile ice-cold
Tyrode salts (Sigma). To determine genotypes of embryos, nonrenal
tissue was developed for
-galactosidase. For metanephric organ
culture, Tyrode salts were replaced with 1:1 Dulbecco's modified
Eagle's medium/Ham's F-12 medium (GIBCO-BRL; Life Technologies, Grand
Island, NY), supplemented with 5% fetal calf serum, penicillin G
sodium (1,000 U/ml), streptomycin sulfate (1,000 U/ml),
and amphotericin B (250 ng/ml). Organ cultures were incubated at
37°C in humidified air with 5%
CO2. Media was replaced 24 h later
and every 48 h thereafter. After 6 days in organ culture, kidneys were
washed with sterile ice-cold PBS, pH 7.3, and one kidney of each pair
was removed from the dish for grafting into anterior eye chambers. The
other kidney was processed for
-galactosidase development by first
fixing in 0.2% paraformaldehyde in 0.1 M PIPES, pH 6.9, at 4°C.
Tissues were then cryoprotected by incubating overnight in 30% sucrose
in PBS containing 2 mM MgCl2 at
4°C, placed in optimal cutting temperature compound (OCT; Miles,
Elkhart, IN), and frozen in isopentane chilled in a dry
ice-acetone bath. Cryostat sections (~6 µm) were cut, air dried,
and postfixed in 0.2% paraformaldehyde in 0.1 M PIPES, pH 6.9, at
4°C for 10 min. Sections were washed three times in PBS plus 2 mM
MgCl2, incubated in detergent
rinse for 10 min on ice, and placed in color development solution
overnight as described above. Slides were postfixed in 4%
paraformaldehyde in PBS, dehydrated through graded ethanol, cleared in
xylene, and coverslipped.
Grafting procedures. Anterior eye
chamber allografts of fetal kidneys grown in organ culture were
established as described previously (22). In brief, adult C57BL/6J
hosts were anesthetized by intraperitoneal injection of a
ketamine/xylazine combination (100 mg/15 mg per kg body wt). Once
anesthetized, tropicamide was applied to the eye to dilate the iris.
The cornea was incised with a 27-gauge needle, and the incision
extended ~2 mm with Vannas scissors. Organ-cultured
Flk1 +/
kidneys previously
freed from tissue culture dishes were transferred into the anterior
chamber via the corneal incision and positioned over the iris.
Antibiotic ophthalmic ointment was applied to the eye, and grafts were
allowed to develop in oculo for 7 days. Grafts were then processed for
-galactosidase histochemistry and microscopy, as described above for
organ-cultured kidneys.
Image analysis of anterior chamber
grafts. Cryostat sections taken at ~120-µm
intervals from eight separate anterior chamber grafts of organ-cultured
kidneys were developed for
-galactosidase histochemistry, and
microscopic images were digitized, using a CH-250 charge-coupled device
camera (Photometrics, Tucson, AZ). Areas of the sections occupied by
glomeruli and tubules and areas occupied by Flk1-positive vascular
structures and cells were measured with IPLab Spectrum 3.0 software
(Signal Analytics, Vienna, VA). Measurements were then expressed as a
percentage of total graft area for each section and averaged for each
graft. Data were statistically analyzed by calculation of a correlation
coefficient using Lotus 123 Release 5 software (Lotus Development,
Cambridge, MA).
 |
RESULTS |
Flk1 expression in E10
Flk1tm1Jrt mice.
As seen previously (27), mice that were homozygous for the
Flk1 mutation died in utero at
~E8.5, due to failure of endothelial
and hematopoietic development. However, heterozygous mutants, which
expressed LacZ instead of Flk1 in one allele, developed
normally. Figure 1 illustrates three E10 littermates processed for
-galactosidase histochemistry. A homozygous null mutant
(Flk1
/
), in which
development was arrested at ~E8.5,
is much smaller than its heterozygote
(Flk1 +/
) and wild-type
(Flk1 +/+) counterparts (Fig. 1).

View larger version (95K):
[in this window]
[in a new window]
|
Fig. 1.
Embryonic day 10 (E10) littermates were taken from
crosses between heterozygous
Flk1tm1Jrt
(Flk1 +/ ) mice and processed
for -galactosidase histochemistry. Nonviable
Flk1 / embryo
(A) is much smaller than the
Flk1 +/ embryo
(B) or wild-type counterpart
(C), due to developmental arrest at
~E8.5. Note that
both Flk1 / and
Flk1 +/ express
-galactosidase and hence are intensely blue.
|
|
Flk1 expression in embryonic kidneys.
We examined three different stages in early kidney development for the
presence and distribution of cells expressing Flk1. Shown in Fig.
2A is a
cross section at the posterior third of the hindlimb bud of a
mid-E10 Flk1 +/
embryo. At this time,
the right metanephric blastema consists of a group of densely
packed round to oval-shaped mesenchymal cells, surrounded by an outer
layer of elongated spindle-shaped cells. Cells expressing Flk1 were
found intermittently within this outer layer (Fig.
2A) but were not present within
central regions of the metanephric blastema itself at this stage.
Also shown on the left of Fig.
2A is the ureteric bud, which is
sprouting from the ventrally located nephric duct and has begun to
penetrate the metanephric blastema. Endothelia of the aorta
and numerous cells in the developing limb buds also expressed
Flk1 in the mid-E10 embryo (Fig.
2A).

View larger version (163K):
[in this window]
[in a new window]
|
Fig. 2.
Sections through E10
(A) and
E11
(B)
Flk1 +/ embryos color developed
with X-gal. A: Flk1 expression (blue)
is seen in intermittent cells (arrows) surrounding but not within the
metanephric blastemata (MB). In left
MB of this E10 section, the ureteric
bud (UB) is beginning to sprout from the nephric duct (ND). Also note
Flk1 expression in the endothelium of the dorsal aorta (A) and in cells
of the limb bud (LB). HG, hindgut. B:
Flk1-positive cells are seen intermittently surrounding the metanephroi
and near the ureteric bud (UB). A small Flk1-positive vessel (arrows)
entering the right metanphros at its ventral aspect lies lateral to the
ureteric bud. Note the nephric duct (ND), which is ventral to the left
metanephros. Endothelium of the dorsal aorta (A) and cardinal veins
(CV) also express Flk1.
|
|
Cells expressing Flk1 were first seen within metanephroi at
E11 (Fig.
2B). These internal Flk1-positive
cells were usually seen near the unbranched ureteric bud, and
continuities among these cells and those of the peripheral network
encapsulating the metanephroi could be clearly discerned (Fig.
2B). These earliest vascular
connections between intra- and extra-metanephric sites took place in
ventromedial and ventrolateral regions of the developing kidney, near
the site of ingress of the ureteric bud from the underlying nephric
duct (Fig. 2B). A vessel that
directly connected the aorta with the metanephros was not seen in any
of the two E10 or three
E11 embryos examined.
By E12, more cells expressing Flk1
were present within the metanephroi proper (Fig.
3). In some cases, an apparent capillary network of Flk1-positive cells could be seen near the ureteric bud, and
some of these vessels contained obvious lumens (Fig. 3). In addition to
this internal Flk1-positive microvasculature, cells expressing Flk1
surrounded the E12 metanephros as seen
in earlier stages (Fig. 3).

View larger version (148K):
[in this window]
[in a new window]
|
Fig. 3.
Section through metanephros dissected from an
E12 Flk1 +/ embryo. A capillary
network (arrows), in which a lumen is present, is seen developing
adjacent to both the medial and lateral aspects of the ureteric bud
(UB). A Flk1-positive vascular network (arrowheads) still surrounds the
developing kidney.
|
|
Flk1 expression in newborn kidney. In
the nephrogenic zone immediately beneath the newborn kidney capsule,
numerous Flk1-positive cells were seen in the vascular clefts of the
early comma- and S-shaped nephric figures (Fig.
4, A and
B). Flk1 was also highly expressed
in endothelial cells of capillary-loop stage glomeruli and in
developing vessels throughout the immature outer cortex (Fig. 4,
A and
C). In more mature, inner cortical
regions of the newborn kidney, Flk1 was still highly expressed in
glomerular capillaries, afferent and efferent arterioles, and arteries
(Fig. 4A). Weaker expression of Flk1
was evident in peritubular capillary endothelium and isolated cells
throughout the cortical interstitium (Fig. 4). Flk1 expression was not
detected, however, in any glomerular or tubular epithelial cells at any
stage of nephron development. Likewise, mesangial areas of late
capillary loop and maturing stage glomeruli did not contain
Flk1-positive cells (Fig. 4, A and
C).

View larger version (162K):
[in this window]
[in a new window]
|
Fig. 4.
Color-developed section through newborn
Flk1 +/ mouse kidney.
A: Flk1-positive endothelium is seen
throughout the cortex. Below the kidney capsule (C) in the subcapsular
nephrogenic zone (NZ), Flk1-positive cells are seen in assembling
capillaries (arrows). In the more mature inner cortex, endothelium of
capillary loop (CL) and maturing glomeruli (G), as well as afferent and
efferent arterioles (A), all express Flk1.
B: higher-magnification view of the
nephrogenic zone shows isolated Flk1-positive cells (arrowheads) in the
subcapsular cortex and others in vascular clefts of comma- and S-shaped
glomeruli (arrows). C:
higher-magnification view of capillary loop stage glomeruli
(CL) shows intense Flk1 expression by glomerular endothelium. However,
mesangial areas do not express Flk1.
|
|
Flk1 expression in the adult kidney.
In comparison with the newborn kidney, Flk1 expression was
downregulated in the adult (Fig. 5). All
glomerular capillaries still expressed Flk1, although the intensity of
-galactosidase reaction product was less than that seen in the
capillaries of maturing glomeruli in newborn kidney (compare Fig. 4,
A and
C, with Fig. 5). The mesangium in adult glomeruli did not contain Flk1-positive cells. Peritubular capillary endothelium and possibly some interstitial cells were weakly
positive for Flk1, whereas arterioles, arteries, and other vessels of
the adult kidney no longer expressed Flk1 (Fig. 5).

View larger version (186K):
[in this window]
[in a new window]
|
Fig. 5.
Flk1 expression in adult Flk1
+/ mouse. Expression is limited to glomerular and peritubular
capillary endothelium (arrowheads). Mesangial cells (M) do not express
Flk1, and endothelium of arterioles (arrows) are now negative.
|
|
Flk1 expression in organ-cultured
metanephroi. Sections from
E12 kidneys that had been maintained
for 6 days in organ culture and then color developed with X-gal are
shown in Fig. 6. Expression of Flk1 was
occasionally seen in cells located within and under the capsule of
organ-cultured rudiments, but no expression was detected in the
avascular "glomeruli" that developed in vitro (Fig. 6). A few
individual cells expressing Flk1 were also seen within mesenchymal
areas, but the presence of Flk1-positive cells within defined vascular
structures was not observed in kidneys maintained under standard organ
culture conditions (Fig. 6).

View larger version (121K):
[in this window]
[in a new window]
|
Fig. 6.
E12 Flk1 +/ metanephroi that were
maintained in organ culture for 6 days and then color developed for
-galactosidase histochemistry. A few Flk1-positive cells
(arrowheads) are seen just beneath the capsule and within mesenchymal
areas. Note avascular glomeruli (G,
inset) that do not express Flk1.
|
|
Flk1 expression in anterior chamber grafts of
organ-cultured kidneys. We previously reported that,
although vessels did not form in organ-cultured kidneys in vitro, when
these cultured kidneys were grafted into anterior eye chambers,
microvessels were quickly established, and their endothelia originated
from the engrafted kidneys (22). To evaluate this process further,
E12
Flk1 +/
kidneys that had been
maintained in organ culture for 6 days were grafted into anterior eye
chambers of wild-type hosts. Grafts were removed 7 days after
implantation and processed for
-galactosidase histochemistry. Shown
in Fig. 7A
is a section through a well-developed graft that is virtually
indistinguishable from a typical section through a newborn
Flk1 +/
kidney (Fig.
4A). Numerous glomeruli, ranging
from S-shaped, capillary-loop, and maturing stages, were present within
grafts, and the pattern of Flk1 expression in endothelial cells
appeared identical to that seen in the newborn kidney. On the other
hand, some grafts did not develop so extensively (Fig. 7B). In such grafts, relatively few
tubules and glomeruli developed, but when present, these structures
were always found in regions that also contained Flk1-positive
vasculature (Fig. 7B). In contrast, areas within grafts that contained large amounts of undifferentiated mesenchyme were poorly vascularized (Fig.
7B).

View larger version (191K):
[in this window]
[in a new window]
|
Fig. 7.
Section from E12 Flk1 +/ kidneys that had been
maintained for 6 days in organ culture before grafting into the
anterior eye chambers of C57BL/6J hosts. Grafts were removed 7 days
after implantation and processed for -galactosidase histochemistry.
A: well-developed graft, which is
morphologically very similar to the newborn
Flk1 +/ kidney (Fig.
4A) has extensive glomerular (G) and
tubular development and abundant Flk1-positive vasculature.
B: less well-developed graft contains
few glomeruli (G) and tubules and much less Flk1-positive vasculature.
Note large area of undifferentiated mesenchyme (M,
bottom) that is poorly vascularized.
|
|
To determine whether there was a relationship between nephrogenesis and
vascular development, areas of graft sections occupied by glomeruli and
tubules and areas occupied by Flk1-positive vasculature were measured.
The mean percentage of areas occupied by nephric structures and
vessels, respectively, are shown in Table
1. A correlation of these means, depicted
graphically in Fig. 8, indicates a positive linear
relationship between glomerulo- and tubulogenesis within grafts and
vascular development.
View this table:
[in this window]
[in a new window]
|
Table 1.
Mean percentages of areas occupied by glomeruli and tubules and
Flk1-positive vasculature, respectively, in anterior chamber grafts
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 8.
Linear relationship of mean percentages of graft areas occupied by
glomeruli and tubules and Flk1-positive vasculature, respectively, of
values shown in Table 1. Symbols correspond with
grafts 1-8 in Table 1.
|
|
 |
DISCUSSION |
In this study, we used heterozygous
Flk1tm1Jrt
transgenic mice to visualize directly Flk1 expression by
differentiating endothelial cells in the developing kidney. First, we
found that, beginning at E10, a
Flk1-positive vascular plexus surrounded the metanephric blastema. On
E11, a metanephric microvascular
network assembled around the ureteric bud, and this occurred before a
distinguishable renal artery connected the metanephros directly with
the aorta. Second, Flk1 expression was ubiquitous in endothelium of the
newborn kidney, including cells of forming capillaries, developing
glomeruli, and larger blood vessels. In the adult kidney, however, Flk1
expression was diminished and found only in glomerular and peritubular
capillary endothelium. Third, when E12
metanephroi were placed in organ culture, Flk1-positive cells were
arrested from further development, and neither formed vessels nor
contributed to "glomeruli" that developed in vitro. However, on
grafting organ-cultured kidneys into anterior eye chambers of adult
mice, Flk1-positive cells were released from arrest and vascularized
engrafted kidneys in an organotypic manner. Finally, there was a
positive linear relationship between renal epithelial differentiation
and vascular development within these grafts, suggesting a strong
interdependence between metanephrogenesis and vascularization in vivo.
The metanephric blastema begins as a cord of mesenchymal cells, which
is derived from the intermediate mesoderm of the urogenital ridge. At
E11 the ureteric bud, a branch of the
nephric duct, grows into the blastema, and metanephrogenesis begins
(12, 26). We first observed Flk1 expression in a loose network of cells surrounding the blastema at E10, and,
by E11, cells expressing Flk1 were
present within the metanephros and located near the ureteric bud. By
E12, these Flk1-positive cells had
assembled into a more complex capillary network and patent microvessels were observed. Overall, these findings agree with a previous study using anti-erythrocyte immunofluorescence staining that demonstrated a
similar network surrounding the E11
metanephros and noted that erythrocytes were found within metanephroi
by E11.5 (24). The cells expressing
Flk1 in the E11 and
E12 metanephroi also correspond with
binding studies using the
-D-galactose-specific lectin, Bandeiraea simplicifolia isolectin
B4
(BSLB4) (10), which specifically labels embryonic mouse endothelium (3).
Surprisingly, the first vascular connections with metanephroi were not
via a direct branch from the dorsal aorta. Instead, initial vascular
entry came from the Flk1-positive plexus surrounding the metanephroi,
and a vessel projected into the metanephros from its ventral aspect
alongside the ingressing ureteric bud. Earlier three-dimensional
reconstructions of dissected E11
kidney serial sections suggested that a
BSLB4-positive microvascular
network stemmed from sites near the ureteric bud (10), which is
therefore in agreement with the Flk1 expression patterns shown here.
The sections from intact E10 and
E11 embryos also illustrate some unexpected anatomical relationships. As illustrated in Fig. 2, paired
metanephroi of E10 and
E11 embryos occupy the posterior third
of the abdomen at the level of the hindlimb buds. The ureteric buds
enter metanephroi at their ventral aspects, as do the first metanephric
vessels (Fig. 2B), whereas the aorta
is dorsomedial to the metanephroi at this time. In other words, kidneys
begin development in the posterior abdominal cavity overlying the
future ureter, and our findings show that initial vascular connections enter the metanephroi ventrally. In the adult mouse, however, the
kidneys are dorsally positioned in the anterior third of the abdomen,
and the renal artery and ureter enter kidneys at their medial aspects
or hili and project laterally. Therefore, as embryonic development
progresses, the kidneys move anteriorly, and their hili pivot to assume
their final orientation in the postnatal animal. Presumably, the
perimetanephric vascular network seen here also declines as the
intrarenal vasculature becomes established and linked to the renal
artery.
Whether the initial solitary capillary seen alongside the ureteric bud
(Fig. 2B) subsequently branches
repeatedly to generate all vessels of the kidney by angiogenesis also
remains to be determined. We favor alternative possibilities, however.
First, metanephric blastemal mesenchymal cells located near the
ureteric bud might differentiate in situ into angioblasts, which then
proliferate and form an internal vascular network by vasculogenesis.
Alternatively, invasive angioblasts from surrounding mesoderm might
migrate into metanephroi, proliferate, and assemble into vascular
structures near the ureteric bud. Such invasive angioblasts have been
identified previously in quail chick chimeras, in which migratory
endothelial precursors move from transplanted mesoderm into host
embryonic mesenchyme to form hybrid vessels (14, 16). Similarly, when we implanted E12 metanephroi from
wild-type mice into kidneys of newborn ROSA26 transgenic mice and vice
versa, we found that host endothelium contributed significantly to
glomerular microvasculature of the graft and that chimeric vessels
formed in both the engrafted kidney and adjacent host tissue (22).
Clearly, endothelial precursors migrated between the graft and host,
demonstrating that, at least in this intrarenal graft system, cells
behaving as invasive angioblasts are indeed present in
E12 and newborn kidneys. Our results
from anterior chamber grafts of organ-cultured
E12 kidneys, discussed further below,
also point to the existence of angioblasts within metanephroi.
Nevertheless, none of our experiments can define whether these
angioblasts originated from the metanephric blastema exclusively or
came from the surrounding extrarenal mesoderm.
When we examined the newborn mouse kidney cortex for Flk1, the receptor
was expressed intensely by all vascular endothelial cells, particularly
those in arterioles and glomeruli. Scattered cells in the cortical
mesenchyme, probably representing angioblasts, also expressed Flk1.
Generally in agreement with previous in situ hybridization experiments
(28) and our earlier immunolocalization results (22), Flk1 was
downregulated in the adult, and its expression was maintained only in
glomerular and peritubular capillaries. The persistent expression of
Flk1 specifically in these sites indicates a role for the receptor in
these but not other vascular structures of the mature kidney. Others
have speculated that the expression of Flk1 in glomeruli and coordinate
expression of VEGF in podocytes may be responsible for maintenance of
the specialized fenestrated phenotype of glomerular endothelium (28).
Along these lines, VEGF has been shown to induce fenestrations in vivo in normally nonfenestrated venular and capillary endothelium of cremaster muscle and skin (23).
To evaluate the capacities of metanephric angioblasts further, we
maintained E12
Flk1 +/
kidneys in organ
culture and evaluated the expression of the receptor in vitro. Our
results show that although limited tubulogenesis and glomerular
epithelial tuft formation progressed in vitro, proliferation of
Flk1-positive cells and differentiation of endothelium was arrested. We
observed a few cells expressing Flk1 in organ culture, but they did not assemble into recognizable vascular structures nor were they found within the glomerular epithelial tufts. Virtually identical results on
failure of metanephric vascular growth in vitro have been reported recently on organ culture of embryonic kidneys from
Tie1/LacZ transgenic mice (15). Using simple
morphologic criteria, a number of other investigators have also shown
that, when embryonic kidneys are maintained under typical organ culture
conditions, tubulogenesis proceeds, but vascular development does not
occur (1, 4). Nonetheless, when we grafted organ-cultured
Flk1 +/
kidneys into anterior
eye chambers of normal mice, cells expressing Flk1 quickly proliferated
and differentiated into microvascular and glomerular endothelia of
engrafted kidneys. These cells could only have come from the graft,
because the wild-type host animals lacked the LacZ transgene. We can safely
conclude, therefore, that microvessels that formed after grafting
organ-cultured kidneys did not arise from angiogenic sprouts
originating within engrafted kidneys or in the host. Instead, our
studies show that intrinsic angioblasts assembled the graft
microvasculature by vasculogenesis. These vasculogenic angioblasts
within the grafts were either derived 1) directly from the relatively few
cells expressing Flk1 that were already present at the time of grafting
or 2) from metanephric mesenchymal
derivatives that began expressing Flk1 only after grafting. Of course,
both possibilities may have occurred concurrently, and future studies
limiting the survival of Flk1-positive cells in organ culture should
clarify this question.
When we measured the areas within grafts occupied by Flk1-positive
cells and vessels and areas occupied by glomeruli and tubules, respectively, we obtained a correlation coefficient of +0.89. In other
words, extensive vascular development corresponded with extensive
glomerulo- and tubulogenesis, whereas poor vessel development coincided
with a lack of epithelial differentiation. This strongly positive,
linear relationship between formation of Flk1-positive vasculature and
glomerular and tubular development within anterior chamber grafts
therefore suggests an interdependence between these processes in vivo.
Although at first glance this is hardly a profound finding, the
hemodynamic and other biophysical factors potentially important for
organotypic renal vascular development in situ in the abdomen are
likely to be considerably different than those in oculo. In addition,
when rat metanephroi are organ cultured under hypoxic (3%
O2) conditions, VEGF mRNA has
been shown to be upregulated, and this is accompanied by some vessel
development and increased tubular epithelial differentiation compared
with explants grown at normoxia (29). Moreover, these hypoxic effects can be prevented by addition of anti-VEGF antibodies to the cultures (29), implicating VEGF as a mediator of epithelial tubulogenesis in
vitro. The VEGF-mediated effects in hypoxic organ cultures must also be
independent of hemodynamic and humoral factors, because endothelial
development in vitro can neither restore normoxia nor deliver blood to
the explant. Administration of anti-VEGF antibodies to newborn mice in
vivo has also been shown to impair glomerulogenesis and tubulogenesis
in the intact kidney (13). Because VEGF receptors have not been
observed in renal epithelial cells previously (11, 28) and we did not
detect Flk1 expression in kidney epithelium at any stage of
development, we suspect that VEGF probably facilitates tubular
development in vitro and in vivo by promoting endothelial cell
differentiation. Taken together, these data strongly suggest that
nephron epithelial development is, among other things, reliant on
paracrine signals from differentiating endothelial cells.
In summary, examination of heterozygous
Flk1tm1Jrt mice
enabled us to view directly some of the early morphogenetic events in
assembly of the renal microvasculature. The results from the anterior
chamber grafts of organ-cultured kidneys also provide additional
evidence for the presence of vasculogenic angioblasts within the
metanephros, but whether these cells stem from
1) metanephric mesenchyme,
2) invasive angioblasts, or
3) the initial metanephric vessels
that connect to the perimetanephric vascular plexus, is undefined.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Juan M. Navia for advice on the statistical analysis
of anterior chamber grafts.
 |
FOOTNOTES |
Funds came from National Institute of Diabetes and Digestive and Kidney
Diseases Grants DK-34972 and DK-52483. B. Robert received a Suzanne
Oparil Fellowship from the American Heart Association, Alabama
Affiliate.
Address for reprint requests: D. R. Abrahamson, Dept. of Cell Biology,
6th Floor Volker Hall, 1670 Univ. Blvd., Univ. of Alabama at
Birmingham, Birmingham, AL 35294-0019.
Received 12 December 1997; accepted in final form 5 March 1998.
 |
REFERENCES |
1.
Bernstein, J.,
F. Cheng,
and
J. Roszka.
Glomerular differentiation in metanephric culture.
Lab. Invest.
45:
183-190,
1981[Medline].
2.
Carmeliet, P.,
V. Ferreira,
G. Breier,
S. Pollefeyt,
L. Kieckens,
M. Gertsenstein,
M. Fahrig,
A. Vandenhoeck,
K. Harpal,
C. Eberhardt,
C. Declerq,
J. Pawling,
L. Moons,
D. Collen,
W. Risau,
and
A. Nagy.
Abnormal blood vessel development, and lethality in embryos lacking a single VEGF allele.
Nature
380:
435-438,
1996[Medline].
3.
Coffin, J. D.,
J. Harrison,
S. Schwartz,
and
R. Heimark.
Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo.
Dev. Biol.
148:
551-562,
1991.
4.
Ekblom, P.
Formation of basement membranes in the embryonic kidney: an immunological study.
J. Cell Biol.
91:
1-10,
1981[Abstract/Free Full Text].
5.
Ferrara, N.,
K. Carver-Moore,
H. Chen,
M. Dowd,
L. Lu,
K. O'Shea,
L. Powell- Braxton,
K. J. Hillan,
and
M. W. Moore.
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.
Nature
380:
439-442,
1996[Medline].
6.
Ferrara, N.,
and
T. Davis-Smyth.
The biology of vascular endothelial growth factor.
Endocr. Rev.
18:
4-25,
1997[Abstract/Free Full Text].
7.
Fong, G.,
J. Rossant,
M. Gerstenstein,
and
M. L. Breitman.
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.
Nature
376:
66-70,
1995[Medline].
8.
Hanahan, D.
Signaling vascular morphogenesis and maintenance.
Science
277:
48-50,
1997[Free Full Text].
9.
Hogan, B.,
R. Beddingtton,
F. Constantini,
and
E. Lacy.
Manipulating the Mouse Embryo: A Laboratory Manual (2nd. ed.). Plainview, NY: Cold Spring Harbor Laboratory, 1994.
10.
Hyink, D. P.,
D. C. Tucker,
P. L. St. John,
V. Leardkamolkarn,
M. A. Accavitti,
C. K. Abrass,
and
D. R. Abrahamson.
Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F886-F899,
1996[Abstract/Free Full Text].
11.
Kaipainen, A.,
J. Korhonen,
K. Pajusola,
O. Aprelikova,
M. G. Persico,
B. I. Terman,
and
K. Alitalo.
The related FLT4, FLT1, and KDR tyrosine kinases show distinct expression patterns in human fetal endothelial cells.
J. Exp. Med.
178:
2077-2088,
1993[Abstract/Free Full Text].
12.
Kanwar, Y. S.,
F. A. Carone,
A. Kumar,
J. Wada,
K. Ota,
and
E. I. Wallner.
Role of extracellular matrix, growth factors and proto-oncogenes in metanephric development.
Kidney Int.
52:
589-606,
1997[Medline].
13.
Kitamoto, Y.,
H. Tokunga,
and
K. Tomita.
Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.
J. Clin. Invest.
99:
2351-2357,
1997[Medline].
14.
Kurz, H.,
T. Gärtner,
P. S. Eggli,
and
B. Christ.
First blood vessels in the avian neural tube are formed by a combination of dorsal angioblast immigration and ventral sprouting of endothelial cells.
Dev. Biol.
173:
133-147,
1996[Medline].
15.
Loughna, S.,
P. Hardman,
E. Landels,
L. Jussila,
K. Alitalo,
and
A. S. Woolf.
A molecular and genetic analysis of renal glomerular capillary development.
Angiogenesis
1:
84-101,
1997.
16.
Noden, D. W.
Embryonic origins and assembly of blood vessels.
Am. Rev. Respir. Dis.
140:
1097-1103,
1989[Medline].
17.
Peters, K. G.,
C. De Vries,
and
L. T. Williams.
Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth.
Proc. Natl. Acad. Sci. USA
90:
8915-8919,
1993[Abstract/Free Full Text].
18.
Puri, M. C.,
J. Rossant,
K. Alitalo,
A. Bernstein,
and
J. Partanen.
The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.
EMBO J.
14:
5884-5891,
1995[Medline].
19.
Risau, W.
Embryonic angiogenesis factors.
Pharmacol. Ther.
51:
371-376,
1991[Medline].
20.
Risau, W.,
and
I. Flamme.
Vasculogenesis.
Ann. Rev. Cell Dev. Biol.
11:
73-91,
1995.[Medline]
21.
Risau, W.
Mechanisms of angiogenesis.
Nature
386:
671-674,
1997[Medline].
22.
Robert, B.,
P. L. St. John,
D. P. Hyink,
and
D. R. Abrahamson.
Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts.
Am. J. Physiol.
271 (Renal Fluid Electrolyte Physiol. 40):
F744-F753,
1996[Abstract/Free Full Text].
23.
Roberts, W. G.,
and
G. E. Palade.
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.
J. Cell Sci.
108:
2369-2379,
1995[Abstract].
24.
Sariola, H.,
P. Ekblom,
and
L. Saxén.
Restricted developmental options of the metanephric mesenchyme.
In: Embryonic Development. Part B. Cellular Aspects, edited by M. Burger,
and R. Weber. New York: Liss, 1982, p. 425-431.
25.
Sato, T. N.,
Y. Tozawa,
U. Deutsch,
K. Wolburg-Buchholz,
Y. Fujiwara,
M. Gendron- Maguire,
T. Gridley,
H. Wolburg,
W. Risau,
and
Y. Qin.
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
Nature
376:
70-74,
1995[Medline].
26.
Saxén, L.
Organogenesis of the Kidney. Cambridge, UK: Cambridge University, 1987.
27.
Shalaby, F.,
J. Rossant,
T. P. Yamaguchi,
M. Gertsenstein,
X. F. Wu,
M. L. Breitman,
and
A. C. Schuh.
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
Nature
376:
62-66,
1995[Medline].
28.
Simon, M.,
H.-J. Gröne,
O. Jöhren,
J. Kullmer,
H. Plate,
W Risau,
and
E. Fuchs.
Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F240-F250,
1995[Abstract/Free Full Text].
29.
Tufro-McReddie, A.,
V. F. Norwood,
K. W. Aylor,
S. J. Botkin,
R. M. Carey,
and
R. A. Gomez.
Oxygen regulates vascular endothelial growth factor-mediated vasculogenesis and tubulogenesis.
Dev. Biol.
183:
139-149,
1997[Medline].
30.
Yamaguchi, T. P.,
D. J. Dumont,
R. A. Conlon,
M. L. Breitman,
and
J. Rossant.
flk-1 and flt-related receptor tyrosine kinase is an early marker for endothelial precursors.
Development
118:
489-498,
1993[Abstract].
Am J Physiol Renal Physiol 275(1):F164-F172
0002-9513/98 $5.00
Copyright © 1998 the American Physiological Society